Krystal Biotech, Inc. (KRYS) Misses Q1 EPS by 33c

Krystal Biotech, Inc. (NASDAQ: KRYS) reported Q1 EPS of ($1.76), $0.33 worse than the analyst estimate of ($1.43).

For earnings history and earnings-related data on Krystal Biotech, Inc. (KRYS) click here.

You May Also Be Interested In

• Key things to know ahead of SK Hynix’s blockbuster US listing
• ImmuCell reports 11.5% sales rise in Q2 2026, 20.9% gain for first half
• WD-40 Co. (WDFC) Tops Q3 EPS by 76c; offers guidance